CIRM chief: Stem cell 'alpha clinic' plan boosts likelihood of success

If stem cell therapies are to reach patients with diabetes, Alzheimer's, sickle cell and other diseases, the infrastructure for delivering those must be planned and not left to wander, said the president of California's stem cell research funding agency.

http://www.bizjournals.com/sanfrancisco/blog/biotech/2013/05/cirm-embryonic-stem-cells-ips-clinics.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_36+%28Pharmaceutical+Industry+News%29